Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)
Diseases of the Cardiovascular System
What is the purpose of this trial?
Prospective, multi-center, double-blind, randomized pivotal trial to evaluate the safety and effectiveness of the DrugSorb-ATR system for intraoperative removal of ticagrelor in patients undergoing urgent cardiothoracic (CT) surgery with cardiopulmonary bypass (CPB).
- Ages18 years and older
- Trial withCytoSorbents, Inc.
- Start Date06/21/2022
- End Date12/31/2022
- Last Updated11/11/2022
- Study HIC#2000031980